4,5,6,7-tetrahydro-1-(phenylsulfonyl)indole | 104165-42-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4,5,6,7-tetrahydro-1-(phenylsulfonyl)indole
• 英文别名: 4,5,6,7-tetrahydro-1-phenylsulphonylindole；1-(Benzenesulfonyl)-4,5,6,7-tetrahydroindole
• CAS: 104165-42-6
• 化学式: C₁₄H₁₅NO₂S
• 分子量: 261.345
• InChiKey: ZGFUJTAGVDVTKL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  47.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4,5,6,7-tetrahydro-1-(phenylsulfonyl)indole 在 氢氧化钾 、 三氯化铝 、 sodium hydride 作用下， 以 甲醇 、 硝基甲烷 、 二氯甲烷 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 生成
  参考文献：
  名称：

  Synthesis and structure–activity relationships of a series of pyrrole cannabinoid receptor agonists

  摘要：

  We designed and synthesized a series of pyrrole derivatives with the aim of investigating the structure-activity relationship (SAR) for the binding of non-classical agonists to CB1 and CB2 cannabinoid receptors. Superposition of two pyrrole-containing cannabinoid agonists, JWH-007 and JWH-161, allowed us to identify positions 1, 3 and 4 of the pyrrole nucleus as amenable to additional investigation. We prepared the 1-alkyl-2,5-dimethyl-3,4-substituted pyrroles 10a-e, 11a-d, 17, 21, 25 and the tetrahydroindole 15, and evaluated their ability to bind to and activate cannabinoid receptors. Noteworthy in this set of compounds are the 4-bromopyrrole 11a, which has an affinity for CB1 and CB2 receptors comparable to that of well-characterized heterocyclic cannabimimetics such as Win-55,212-2; the amide 25, which, although possessing a moderate affinity for cannabinoid receptors, demonstrates that the 3-naphthoyl group, commonly present in indole and pyrrole cannabimimetics, can be substituted by alternative moieties; and compounds 10d, 11d, showing CB1 partial agonist properties. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(03)00413-9
• 作为产物：
  描述：

  4,5,6,7-四氢吲哚 、 苯磺酰氯 在 四丁基氢氧化铵 sodium hydroxide 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 0.5h， 生成 4,5,6,7-tetrahydro-1-(phenylsulfonyl)indole
  参考文献：
  名称：

  Beddoes, Roy L.; Dalton, Lesley; Joule, John A., Journal of the Chemical Society. Perkin transactions II, 1986, p. 787 - 798

  摘要：

  DOI：

文献信息

• FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF
  申请人：YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD.

  公开号：EP0885883A1

  公开（公告）日：1998-12-23

  The present invention relates to a fused heterocyclic compound of the formula (I) wherein each symbol is as defined in the specification, an optical isomer thereof, a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing a compound of the formula (I), an optical isomer thereof or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable additive, and a medicament containing a compound of the formula (I), an optical isomer thereof or a pharmaceutically acceptable salt thereof. The compound of the present invention is a useful antipsychotic agent effective not only for positive symptoms centering on hallucination and delusion characteristic of the acute stage of schizophrenia, but also negative symptoms of apathy, abulia and autism. The inventive compound is expected to make a highly safe antipsychotic agent associated with less side effects, such as extrapyramidal symptoms and endocrine disturbance, which are observed when a conventional antipsychotic agent having a D2 receptor blocking action is administered. Therefore, the inventive compound can be used as a therapeutic agent for the diseases such as schizophrenia.

  本发明涉及式（I）的融合杂环化合物、其光学异构体、其药用盐、含有式（I）化合物、其光学异构体或其药用组合物的药物组合物。 其中各符号如说明书中所定义；其光学异构体；其药学上可接受的盐；含有式（I）化合物、其光学异构体或其药学上可接受的盐和药学上可接受的添加剂的药物组合物；以及含有式（I）化合物、其光学异构体或其药学上可接受的盐的药物。本发明的化合物是一种有用的抗精神病药物，不仅对精神分裂症急性期特有的以幻觉和妄想为中心的阳性症状有效，而且对冷漠、乏力和自闭等阴性症状也有效。本发明化合物有望成为一种高度安全的抗精神病药物，其副作用较小，如锥体外系症状和内分泌紊乱，这些副作用在使用具有 D2 受体阻断作用的传统抗精神病药物时会出现。因此，本发明化合物可用作精神分裂症等疾病的治疗药物。
• US6187774B1
  申请人：——

  公开号：US6187774B1

  公开（公告）日：2001-02-13
• Synthesis and structure–activity relationships of a series of pyrrole cannabinoid receptor agonists
  作者：Giorgio Tarzia、Andrea Duranti、Andrea Tontini、Gilberto Spadoni、Marco Mor、Silvia Rivara、Pier Vincenzo Plazzi、Satish Kathuria、Daniele Piomelli

  DOI：10.1016/s0968-0896(03)00413-9

  日期：2003.9

  We designed and synthesized a series of pyrrole derivatives with the aim of investigating the structure-activity relationship (SAR) for the binding of non-classical agonists to CB1 and CB2 cannabinoid receptors. Superposition of two pyrrole-containing cannabinoid agonists, JWH-007 and JWH-161, allowed us to identify positions 1, 3 and 4 of the pyrrole nucleus as amenable to additional investigation. We prepared the 1-alkyl-2,5-dimethyl-3,4-substituted pyrroles 10a-e, 11a-d, 17, 21, 25 and the tetrahydroindole 15, and evaluated their ability to bind to and activate cannabinoid receptors. Noteworthy in this set of compounds are the 4-bromopyrrole 11a, which has an affinity for CB1 and CB2 receptors comparable to that of well-characterized heterocyclic cannabimimetics such as Win-55,212-2; the amide 25, which, although possessing a moderate affinity for cannabinoid receptors, demonstrates that the 3-naphthoyl group, commonly present in indole and pyrrole cannabimimetics, can be substituted by alternative moieties; and compounds 10d, 11d, showing CB1 partial agonist properties. (C) 2003 Elsevier Ltd. All rights reserved.
• Beddoes, Roy L.; Dalton, Lesley; Joule, John A., Journal of the Chemical Society. Perkin transactions II, 1986, p. 787 - 798
  作者：Beddoes, Roy L.、Dalton, Lesley、Joule, John A.、Mills, Owen S.、Street, Jonathan D.、Watt, C. Ian F.

  DOI：——

  日期：——